Exhibit 1
Joint Filing Statement
Statement Pursuant to Rule 13d-1(k)(1)
The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Voting Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Corp, beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G.
Dated: February 3, 2022 | ||
Tenor Capital Management Company, L.P. | ||
By: | /s/ Robin Shah | |
Name: | Robin Shah | |
Title: | Managing Member of its general partner, Tenor Management GP, LLC |
Tenor Opportunity Master Fund, Ltd. | ||
By: | /s/ Robin Shah | |
Name: | Robin Shah | |
Title: | Authorized Signatory |
Robin Shah | ||
By: | /s/ Robin Shah | |
Name: | Robin Shah |